Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > General > Visual function rehabilitation needed after TBI, stroke
  • General

Visual function rehabilitation needed after TBI, stroke

Kelsey Moroz

Most patients with a traumatic brain injury (TBI) or stroke experience visual field (VF) defects with unreliable VF test performance, according to a study

In this retrospective, cross-sectional study, best-corrected visual acuity (BCVA), intraocular pressure (IOP), ocular manifestations, and VF test results including VF defect pattern, reliability, and global indices, were compared between 118 patients (236 eyes) with TBI and stroke who underwent VF testing.

Ocular manifestations of TBI patients included:
-Strabismus (11.1%)
-Cataract (4.2%)
-Glaucoma suspect (2.8%)

Ocular manifestations of stroke patients included:
-Cataract (15.2%)
-Strabismus (8.5%)
-Diabetic retinopathy (4.9%)
-Extraocular movement (EOM) limitation (3.0%)
-Glaucoma suspect (3.0%)
-Nystagmus (2.4%)
-Drusen (1.2%)
-Vitreous hemorrhage (1.2%)

VF defect was noted in 85.5% of eyes of patients with TBI and 65.2% of eyes of stroke patients.

VF defect pattern in TBI patients included:
-Scattered (56.4%)
-Homonymous hemianopsia (14.5%)
-Homonymous quadrantanopia (10.9%)
-Total defect (3.6%)

VF defect pattern in stroke patients included:
-Homonymous hemianopsia (31.8%)
-Scattered (16.7%)
-Homonymous quadrantanopia (12.1%)
-Total defect (4.5%)

Only 27.3% of eyes in TBI patients and 24.2% of eyes in stroke patients showed reliable VF indices.

“Our findings suggest that accurate evaluation and rehabilitation of visual function should be a matter of greater concern and emphasis in the management of TBI and stroke patients, besides systemic diseases,” the authors concluded.

Reference
Lee YJ, Lee SC, Wy SY, et al. Ocular Manifestations, Visual Field Pattern, and Visual Field Test Performance in Traumatic Brain Injury and Stroke. J Ophthalmol. 2022;2022:1703806. doi: 10.1155/2022/1703806. PMID: 35036002; PMCID: PMC8759901.

Share

Related Content

  • General

Preserflo associated with fewer complications than Xen63 in glaucoma surgery

  • General

Glaucoma may signal complications in intraocular cancers, review suggests

  • General

XEN63 Gel Stent shows sustained glaucoma control over 3 years

  • General

Triple-layer decellularized amniotic membrane linked to low recurrence and minimal complications

  • General

Best of 2025: Imaging advances and therapeutic progress across ophthalmology

  • Cataract

It has never been a better time to be a cataract surgeon: trends and advancements in cataract and refractive surgery

34 Mins Watch

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon